Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Non-Current Assets (2016 - 2025)

Surgery Partners' Non-Current Assets history spans 12 years, with the latest figure at $7.0 billion for Q4 2025.

  • For Q4 2025, Non-Current Assets rose 2.93% year-over-year to $7.0 billion; the TTM value through Dec 2025 reached $27.5 billion, up 6.63%, while the annual FY2025 figure was $7.0 billion, 2.93% up from the prior year.
  • Non-Current Assets for Q4 2025 was $7.0 billion at Surgery Partners, up from $6.8 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $7.0 billion in Q4 2025 and bottomed at $4.6 billion in Q1 2021.
  • The 5-year median for Non-Current Assets is $5.9 billion (2023), against an average of $5.9 billion.
  • The largest annual shift saw Non-Current Assets grew 21.05% in 2022 before it grew 1.82% in 2023.
  • A 5-year view of Non-Current Assets shows it stood at $5.2 billion in 2021, then grew by 11.4% to $5.8 billion in 2022, then grew by 3.83% to $6.0 billion in 2023, then rose by 13.19% to $6.8 billion in 2024, then increased by 2.93% to $7.0 billion in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Non-Current Assets are $7.0 billion (Q4 2025), $6.8 billion (Q3 2025), and $6.8 billion (Q2 2025).